NCT07822464

Brief Summary

This randomized controlled trial will evaluate whether adding one-session structured cognitive behavioral therapy (CBT)-based smoking-cessation counseling to standardized brief smoking-cessation counseling improves cigarette smoking abstinence among patients with cancer who smoked combustible cigarettes at diagnosis and are still smoking at screening and enrollment. After written informed consent and baseline assessment, all participants will receive the same standardized brief smoking-cessation counseling using a condensed 5A framework. Participants will then be randomly assigned 1:1 to no additional study CBT or to one additional structured CBT-based smoking-cessation session. Follow-up will continue for 3 months after randomization at Campus 3 of Vietnam National Cancer Hospital in Hanoi, Vietnam.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
446

participants targeted

Target at P75+ for not_applicable cancer

Timeline
9mo left

Started Oct 2026

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 16, 2026

Completed
29 days until next milestone

Study Start

First participant enrolled

October 15, 2026

Expected
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2027

Last Updated

September 16, 2026

Status Verified

September 1, 2026

Enrollment Period

9 months

First QC Date

September 10, 2026

Last Update Submit

September 10, 2026

Conditions

Keywords

Smoking CessationCognitive Behavioral TherapyCancerTobacco UseOncology Care

Outcome Measures

Primary Outcomes (1)

  • Self-Reported 7-Day Point-Prevalence Cigarette Smoking Abstinence at 3 Months

    7-day point-prevalence cigarette smoking abstinence will be defined as self-report of no cigarette smoking, not even a puff, during the 7 days preceding the 3-month follow-up assessment. Participants reporting any cigarette smoking, even a puff, during this 7-day period will be classified as not abstinent. No biochemical verification.

    3 months after randomization

Secondary Outcomes (4)

  • Self-Reported 7-Day Point-Prevalence Cigarette Smoking Abstinence at 1 and 2 Months

    1 and 2 months after randomization.

  • : Self-Reported Sustained Cigarette Smoking Abstinence From Month 1 Through Month 3.

    From 1 month through 3 months after randomization

  • At least one intentional quit attempt lasting ≥24 hours during the 3-month follow-up.

    From randomization through 3 months

  • Readiness/Commitment to Quit Cigarette Smoking

    Baseline and 1, 2, and 3 months after randomization

Study Arms (2)

Standardized Brief Smoking-Cessation Counseling Alone

ACTIVE COMPARATOR

Before randomization, all participants receive the same individual face-to-face standardized brief smoking-cessation counseling session lasting approximately 3-5 minutes using a condensed 5A framework. After randomization, participants allocated to the control arm receive no additional study CBT. Study outcome follow-up is identical in both arms.

Behavioral: Standardized Brief Smoking-Cessation Counseling

Standardized Brief Smoking-Cessation Counseling Plus Structured CBT

EXPERIMENTAL

Before randomization, all participants receive the same standardized brief 5A smoking-cessation counseling. After randomization, participants allocated to the intervention arm are offered one additional individual structured CBT-based smoking-cessation counseling session lasting approximately 20-30 minutes. Declining CBT after randomization does not change randomized assignment; follow-up continues if the participant agrees.

Behavioral: Standardized Brief Smoking-Cessation CounselingBehavioral: Add-on One-Session Structured CBT-Based Smoking-Cessation Counseling

Interventions

Common pre-randomization care delivered to all enrolled participants after consent and baseline assessment and before allocation is revealed. One individual face-to-face session lasting approximately 3-5 minutes using a condensed 5A framework (Ask, Advise, Assess, Assist, Arrange).

Standardized Brief Smoking-Cessation Counseling AloneStandardized Brief Smoking-Cessation Counseling Plus Structured CBT

Only participants randomized to the intervention arm are offered one additional individual face-to-face CBT-based smoking-cessation session lasting approximately 20-30 minutes after allocation. Six modules address smoking-related cognitions/beliefs, cognitive restructuring, individualized quit goal/date/plan, triggers/high-risk situations, coping for cravings/withdrawal/stress, and relapse-prevention/lapse management. Delivery is standardized and fidelity is recorded.

Standardized Brief Smoking-Cessation Counseling Plus Structured CBT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older.
  • Diagnosed with cancer.
  • Was smoking combustible cigarettes at the time of cancer diagnosis.
  • Still smoking combustible cigarettes at screening/enrollment.
  • Able to communicate sufficiently and provide reliable study information.
  • Provides written informed consent.

You may not qualify if:

  • Clinically too severe for reliable participation.
  • Cognitive/communication limitations precluding consent or reliable participation.
  • Currently participating in a competing structured smoking-cessation program.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vietnam National Cancer Hospital

Hanoi, 100000, Vietnam

Location

MeSH Terms

Conditions

NeoplasmsTobacco UseSmoking Cessation

Condition Hierarchy (Ancestors)

BehaviorHealth Behavior

Study Officials

  • Nguyen Duc Khoa, MD, PhD

    Vietnam National Cancer Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nguyen Duc Khoa, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDIV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of Center for Training and Technical Transfer

Study Record Dates

First Submitted

September 10, 2026

First Posted

September 16, 2026

Study Start (Estimated)

October 15, 2026

Primary Completion (Estimated)

July 15, 2027

Study Completion (Estimated)

July 15, 2027

Last Updated

September 16, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying reported results may be made available upon reasonable request, subject to ethical requirements, institutional approval, and a data-sharing agreement.

Locations